(Q54222370)

English

Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. (English)

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

phase I clinical trial

0 references

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

author name string

C Bokemeyer

1

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

H J Schmoll

2

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

F Natt

3

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

M Knoche

4

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

R Souchon

6

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

publication date

1 January 1994

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

120

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

754-757

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

12

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

https://scigraph.springernature.com/pub.10.1007/bf01194278

0 references

Treatment of testicular cancer: a new and improved model

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol: a novel investigational antimicrotubule agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New cytostatic drugs in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of taxol given by a 6-hour intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promotion of microtubule assembly in vitro by taxol

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of taxol given as a 3-hour infusion every 21 days

1 reference

https://pubmed.ncbi.nlm.nih.gov/7798304

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01194278

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

1 reference

Europe PubMed Central

26 May 2018

http://europepmc.org/abstract/MED/7798304

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54222370&oldid=1749511144"